XML 43 R33.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Collaboration agreements - Johnson & Johnson (Details)
1 Months Ended 3 Months Ended 6 Months Ended
Feb. 28, 2022
USD ($)
target
performanceObligation
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Collaboration agreements              
Collaboration revenue   $ 2,293,000 $ 10,654,000 $ 11,538,000 $ 18,456,000    
Deferred revenue   116,916,000 134,697,000 116,916,000 134,697,000 $ 125,314,000 $ 147,653,000
Johnson & Johnson Agreement              
Collaboration agreements              
Number of targets designated | target 3            
Upfront payment received $ 40,000,000            
Performance obligations identified | performanceObligation 7            
Revised transaction price   48,000,000   48,000,000      
Johnson & Johnson Agreement | Performance obligations              
Collaboration agreements              
Collaboration revenue   1,800,000 7,500,000 7,900,000 $ 9,100,000    
Johnson & Johnson Agreement | Development milestone achieved              
Collaboration agreements              
Collaboration revenue     $ 2,000,000        
Johnson and Johnson 2024 CMC Arrangement              
Collaboration agreements              
Revised transaction price   5,000,000   5,000,000      
Receivable from customer   1,600,000   1,600,000      
Collaboration revenue       0      
Johnson and Johnson Agreement and Johnson and Johnson 2024 CMC Arrangement              
Collaboration agreements              
Deferred revenue   $ 5,400,000   $ 5,400,000   $ 10,400,000